The prevention and control of bovine viral diarrhea virus (BVDV) infections in cattle are of worldwide concem. 1, 5 Although our understanding of the complex pathogenesis of BVDV has progressed, many aspects of BVDV infection remain elusive. A unique and significant aspect of the pathogenesis of BVDV is the development of persistently infected animals following in utero infection. 1 Although persistently infected animals may constitute only 1-2% of the cattle population 2 they are considered the main source of infection and may serve as reservoirs. 1, 5 Due to the epidemiological significance of persistently infected animals, it is important that possible methods of transmission be investigated. Currently, the recommended prevention and control measures for BVDV are centered around the identification and removal of persistently infected animals and the judicious use of BVDV vaccines. 4,6 Unfortunately, the identification of persistently infected animals has not been emphasized until recently and remains impractical. The purpose of this report is to emphasize the epidemiological significance of animals persistently infected with BVDV, especially in relation to embryo transfer procedures.
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A 5-month-old Holstein heifer, persistently infected with BVDV, was identified in a dairy herd with a history of BVDV infection by virus isolation from nasal and vaginal swabs and serum. The heifer had no detectable levels of BVDV serum antibodies (in indirect fluorescence assay [IFA]) and was kept in isolation for observation and testing. Estrus first was detected at 14 months of age. Following the third heat cycle the heifer was superovulated with follicle-stimulating hormone (days 11-14) and inseminated with BVDV-negative semen (confirmed negative by virus isolation) during the subsequent estrous. Embryo collection was attempted on day 7 (estrus day 0) by standard whole body uterine flush using 2 liters of Dulbecco's phosphate-buffered saline containing 3% BVDV-negative fetal bovine serum (confirmed negative by virus isolation). Virus was not isolated from the flush medium prior to the uterine flush. Only 3 unfertile eggs were identified by microscopic examination in the uterine flush fluid (2 liters).
The titers of BVDV were quantitated in various samples collected from the persistently infected heifer by virus isolation from 10-fold dilutions of the samples. One milliliter of each dilution was inoculated in replicates of 3 onto BVDVnegative secondary bovine turbinate cells passaged 5-10 times in Dulbecco's minimum essential medium containing 10% horse serum. The inoculum was removed after 1 hour and replaced with fresh medium. The cell cultures were incubated for 5 days at 37 C in 5% CO 2 . Noncytopathic BVDV was detected by IFA using an anti-BVDV polyclonal serum prepared in a gnotobiotic calf. Samples collected were feces, serum, urine, vaginal mucus collected during estrus, and uterine flush fluid obtained during embryo collection procedures. Noncytopathic BVDV was detected in all samples tested and the 50% endpoint quantitated as cell culture infective doses/ ml (CCID 50 /ml) ( Table 1 ).
The significance of persistently infected animals in the transmission and maintenance of BVDV in an infected herd can be understood when the levels of virus present in secretions as indicated in Table 1 are considered. Although the transmission of BVDV is likely to occur by direct contact, the possibility of indirect transmission is also increased due to relatively high shedding of virus in the feces ( 10 4 CCID 50 / g) and mucosal secretions ( 10 6 CCID 50 /ml) ( Table 1) . Although this is a preliminary report involving only 1 persistently infected animal, the findings are important and warrant further investigation into the epidemiological significance of these silent reservoirs of BVDV.
This report documents that BVDV is present at considerably high levels in the uterine environment of a persistently infected animal. The titer of BVDV in 2 liters of uterine flush medium ( 10 2 CCID 50 /ml) would correspond to approximately 10 5 CCID 50 ml of BVDV within the uterine environment. The effects of virus in vivo in the uterine environment of persistently infected animals are unknown. For infectious disease transmission to occur during embryo transfer, the pathogen must be (1) within the ovum or embryo, (2) adherent to the zona pellucida, (3) in the transfer medium, or (4) from the recipient. 7 On the basis of several in vitro and in vivo experiments, it is generally accepted that if the zona pellucida is intact and the embryos are washed adequately then the risk of disease transmission is nonexistent. 3, 7, 8 Therefore quality control is currently centered around adequate washing of embryos before transfer. Nevertheless, it has been suggested that the transmission of BVDV from persistently infected donors during embryo transfer may occur. 5 To date, it has not been demonstrated that embryo washing prevents transmission of BVDV from persistently infected donors to the embryos and/or recipients.
Presently, donor and recipient cattle are not routinely screened to detect persistently infected carriers in most if not all embryo transfer operations. Therefore it is important that the possible risks of BVDV transmission from these animals be studied further. If a carrier calf produced as the result of transmission by embryo transfer develops into a successful breeder, then a maternal viremic family may be established and this virtually would have the same impact as introducing an undesirable trait into elite breeding stock. 4 Until more information on the transmission of BVDV in utero by per-
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Brief communications e 1. Titers of BVDV (CCID 50 /ml) detected in cell culture by an indirect immunofluorescence assay. sistently infected animals is available, serious consideration should be given to the testing of embryo transfer donors and possibly recipients for virus to identify animals that may be persistently infected with BVDV. Also due to high levels of virus present in persistently infected animals, measures to prevent indirect transmission of BVDV between animals should be practiced routinely.
